skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 297,156  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Treatment Outcome remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia
Material Type:
Article
Add to My Research

Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia

Leukemia, 2019-11, Vol.33 (11), p.2575-2584 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;COPYRIGHT 2019 Nature Publishing Group ;The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0887-6924 ;EISSN: 1476-5551 ;DOI: 10.1038/s41375-019-0472-2 ;PMID: 30967620

Full text available

2
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50
Material Type:
Article
Add to My Research

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50

Journal of clinical oncology, 2021-07, Vol.39 (21), p.2339-2349 [Peer Reviewed Journal]

2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.00174 ;PMID: 33872070

Full text available

3
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
Material Type:
Article
Add to My Research

Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer

Journal of clinical oncology, 2017-06, Vol.35 (17), p.1884-1890 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.71.7397 ;PMID: 28296582

Full text available

4
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Material Type:
Article
Add to My Research

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

New England Journal of Medicine, 2021-08, Vol.385 (7), p.585-594 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2108891 ;PMID: 34289274

Digital Resources/Online E-Resources

5
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164
Material Type:
Article
Add to My Research

Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164

Journal of clinical oncology, 2020-01, Vol.38 (1), p.11-19 [Peer Reviewed Journal]

2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.02107 ;PMID: 31725351

Full text available

6
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Material Type:
Article
Add to My Research

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

Journal of clinical oncology, 2018-07, Vol.36 (20), p.2017-2023 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2018.78.8034 ;PMID: 29746227

Full text available

7
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic
Material Type:
Article
Add to My Research

Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic

Annals of oncology, 2020-08, Vol.31 (8), p.1065-1074 [Peer Reviewed Journal]

2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;2020 The Author(s) 2020 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2020.05.009 ;PMID: 32442581

Full text available

8
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
Material Type:
Article
Add to My Research

MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer

Journal of clinical oncology, 2017-11, Vol.35 (32), p.3638-3646 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2017.75.6155 ;PMID: 28968163

Full text available

9
High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
Material Type:
Article
Add to My Research

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

Cancer discovery, 2017-06, Vol.7 (6), p.586-595

2017 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-16-1396 ;PMID: 28365644

Full text available

10
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
Material Type:
Article
Add to My Research

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

The New England journal of medicine, 2022-02, Vol.386 (6), p.509-520 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2116044 ;PMID: 34914868

Full text available

11
AKI in Hospitalized Patients with COVID-19
Material Type:
Article
Add to My Research

AKI in Hospitalized Patients with COVID-19

Journal of the American Society of Nephrology, 2021-01, Vol.32 (1), p.151-160 [Peer Reviewed Journal]

Copyright © 2021 by the American Society of Nephrology. ;Copyright © 2021 by the American Society of Nephrology 2021 ;ISSN: 1046-6673 ;EISSN: 1533-3450 ;DOI: 10.1681/ASN.2020050615 ;PMID: 32883700

Full text available

12
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Material Type:
Article
Add to My Research

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

The New England journal of medicine, 2021-04, Vol.384 (15), p.1412-1423 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2101765 ;PMID: 33626250

Full text available

13
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection
Material Type:
Article
Add to My Research

Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection

Journal of the American College of Cardiology, 2020-08, Vol.76 (5), p.533-546 [Peer Reviewed Journal]

2020 ;Published by Elsevier Inc. ;COPYRIGHT 2020 Elsevier B.V. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2020.06.007 ;PMID: 32517963

Full text available

14
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Material Type:
Article
Add to My Research

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The Lancet (British edition), 2021-05, Vol.397 (10285), p.1637-1645 [Peer Reviewed Journal]

2021 Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2021 Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2021. Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license 2021 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00676-0 ;PMID: 33933206

Full text available

15
Effective treatment of severe COVID-19 patients with tocilizumab
Material Type:
Article
Add to My Research

Effective treatment of severe COVID-19 patients with tocilizumab

Proceedings of the National Academy of Sciences - PNAS, 2020-05, Vol.117 (20), p.10970-10975 [Peer Reviewed Journal]

Copyright © 2020 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences May 19, 2020 ;Copyright © 2020 the Author(s). Published by PNAS. 2020 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2005615117 ;PMID: 32350134

Full text available

16
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial
Material Type:
Article
Add to My Research

Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial

Blood, 2020-06, Vol.135 (24), p.2137-2145 [Peer Reviewed Journal]

2020 American Society of Hematology ;2020 by The American Society of Hematology. ;2020 by The American Society of Hematology 2020 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020004856 ;PMID: 32219442

Full text available

17
Hemicraniectomy in Older Patients with Extensive Middle-Cerebral-Artery Stroke
Material Type:
Article
Add to My Research

Hemicraniectomy in Older Patients with Extensive Middle-Cerebral-Artery Stroke

The New England journal of medicine, 2014-03, Vol.370 (12), p.1091-1100 [Peer Reviewed Journal]

Copyright © 2014 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1311367 ;PMID: 24645942 ;CODEN: NEJMAG

Full text available

18
Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors
Material Type:
Article
Add to My Research

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2018-06, Vol.36 (16), p.1611-1618 [Peer Reviewed Journal]

2018 by American Society of Clinical Oncology 2018 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.76.2229 ;PMID: 29437535

Full text available

19
Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial
Material Type:
Article
Add to My Research

Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial

Journal of clinical oncology, 2019-05, Vol.37 (15), p.1316-1325 [Peer Reviewed Journal]

2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.18.00622 ;PMID: 30943123

Full text available

20
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
Material Type:
Article
Add to My Research

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

The lancet oncology, 2016-08, Vol.17 (8), p.1047-1060 [Peer Reviewed Journal]

Dearnaley et al. Open Access article distributed under the terms of CC BY ;2016 Dearnaley et al. Open Access article distributed under the terms of CC BY ;Copyright © 2016 Dearnaley et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Aug 01, 2016 ;2016 Dearnaley et al. Open Access article distributed under the terms of CC BY 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(16)30102-4 ;PMID: 27339115 ;CODEN: LANCAO

Full text available

Results 1 - 20 of 297,156  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (275,483)

Refine My Results

Creation Date 

From To
  1. Before 1974  (23)
  2. 1974 To 1988  (50)
  3. 1989 To 2000  (30,181)
  4. 2001 To 2013  (151,411)
  5. After 2013  (115,491)
  6. More options open sub menu

Subject 

  1. Humans  (297,030)
  2. Middle Aged  (262,691)
  3. Science & Technology  (259,767)
  4. Female  (256,030)
  5. Life Sciences & Biomedicine  (254,919)
  6. Male  (252,534)
  7. Aged  (201,345)
  8. Adult  (166,329)
  9. Retrospective Studies  (77,418)
  10. Biological And Medical Sciences  (74,334)
  11. Medical Sciences  (73,762)
  12. Aged, 80 And Over  (73,310)
  13. Surgery  (65,849)
  14. Follow-Up Studies  (59,309)
  15. Adolescent  (45,162)
  16. Cardiovascular System & Cardiology  (45,130)
  17. Time Factors  (43,642)
  18. Prospective Studies  (41,578)
  19. Young Adult  (39,120)
  20. More options open sub menu

Language 

  1. English  (288,989)
  2. Japanese  (41,101)
  3. Portuguese  (3,312)
  4. German  (2,980)
  5. Spanish  (1,718)
  6. French  (1,337)
  7. Russian  (918)
  8. Chinese  (840)
  9. Polish  (462)
  10. Turkish  (413)
  11. Romanian  (268)
  12. Italian  (240)
  13. Norwegian  (233)
  14. Ukrainian  (232)
  15. Swedish  (131)
  16. Serbian  (95)
  17. Icelandic  (85)
  18. Czech  (78)
  19. Korean  (74)
  20. Hungarian  (65)
  21. More options open sub menu

Searching Remote Databases, Please Wait